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Abstract
Background: Norrin is a potent Wnt pathway ligand. Aberrant activation of this signaling pathway
can result in colon tumors but the role of norrin-based signaling in the genesis of colon cancer, and
its relationship to activation of the pathway by traditional Wnt ligands, is not defined.
Results: Fresh normal human colon tissue and all the cell lines studied expressed mRNA for Fz4,
LRP5 and norrin, except Colo205 which lacked Fz4 expression. Canonical Wnt pathway
throughput was increased slightly in NCM460 following treatment with Wnt3a CM but was
inhibited by Wnt2 and Wnt1. The colon cancer cell line, RKO, responded to Wnt3a CM, Wnt2
and Wnt1 by increasing canonical Wnt pathway throughput. Wnt5a did not affect Wnt pathway
throughput in either cell line. Wnt2, but not Wnt3a, abrogated Fz4 expression in NCM460, but not
in RKO or another colon cancer cell line, HCT116. This effect on Fz4 was confirmed at both the
RNA and protein levels via RT-PCR and a norrin binding assay. The expression of all others 9 Fz
receptors did not change after treatment of NCM460 cells with Wnt2.
Conclusion:  The data suggests that colonic mucosa and colon tumors may possess two
autoregulatory positive Wnt feedback loops, one through canonical signals induced by Wnt:Fz
interactions and one through signals resulting from norrin:Fz4 interactions. The latter interactions
may be modulated via regulation of Fz4 expression by Wnt2. Retention of Fz4 by cancers, in
contrast to the loss of Fz4 by normal mucosal cells, could provide a selective advantage to the
tumor cells. Fz4 expression may play a critical role in responses to Wnt signaling in the tumor
microenvironment.
Background
Signaling through the Wnt pathway begins with Wnt lig-
ands, secreted growth factors that interact with a Frizzled
(Fz) cell surface transmembrane receptor together with
co-receptors of the low-density lipoprotein receptor-
related protein (LRP) family to initiate the signal cascade
[1-3]. Wnt binding to Fz leads to hyperphosphorylation of
Dishevelled [4] which inhibits the activity of glycogen
synthase kinase-3 (GSK-3). This, along with destabiliza-
tion of axin, prevents APC-mediated degradation of β-cat-
enin leading to its accumulation. β-catenin is then
available to bind to members of the lymphoid enhancer
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factor/T-cell factor (LEF/TCF) family of HMG-box tran-
scription factors [5,6] and induce the transcription of
growth regulatory genes such as myc  [7] and cyclinD1
[8,9]. Cell surface expression of LRP5/6 appears to be nec-
essary to induce this β-catenin-dependent (canonical)
Wnt signaling [10]. In its absence, Wnts may bind to Fz
receptors and initiate distinct, non-canonical signaling
cascades [11].
Recently, a non-Wnt ligand has been described that binds
selectively to Fz receptor subtype-4 (Fz4) and induces
canonical Wnt signaling [12-14]. This ligand, norrin,
binds with high (nanomolar) affinity to Fz4 and canoni-
cal pathway activation via this interaction is dependent on
the presence of cell surface LRP5 [12]. Norrin appears to
promote angiogenesis. Overexpression in norrin deficient
mice induces the growth of ocular capillaries [15] and
inactivating mutations results in Norrie disease which is
characterized by ocular vascular defects and sensorineural
deafness related to impaired cochlear vascularization
[16,17]. Abnormalities in Fz4 or LRP5 result in a pheno-
typically similar condition, familial exudative vitreoretin-
opathy (FEVR) characterized by defects in retinal vascular
development [18-21]. The clinical similarities in vascular
phenotypes caused by norrin, Fz4 and LRP5 mutations in
humans and mouse models, along with the high specifi-
city of norrin-Fz4 binding support the hypothesis that
norrin and Fz4/LRP5 form a functional binding group
which is involved in angiogenesis regulation.
Wnt signaling is of paramount importance in the colon,
with >85% of sporadic colon cancers associated with acti-
vating mutations in APC or β-catenin [22]. Other altera-
tions in Wnt pathway components, including LEF1, Fz
receptors and Wnt2 and Wnt5a have been described in
colon cancer which may contribute to regulation of Wnt
signal throughput [23,24]. Whether norrin or Fz4 have
functional relevance in the colon or in the pathogenesis of
colon cancer is unknown. In this study, we demonstrate
for the first time that the components for norrin:Fz4 sign-
aling are present in the human colon and, in vitro, in nor-
mal colonic mucosa-derived cells, endothelial cells and in
colon cancer cells. Additionally, in normal colonic
mucosa-derived cells, Fz4 expression is regulated by
Wnt2. The data suggest that, in vivo, cross-talk between
colon cancer, colonic mucosa and, perhaps, colonic
mucosa-localized endothelial cells may be an important
feature of the tumor microenvironment and may impact
tumor-mediated angiogenesis.
Results
Expression of norrin and norrin receptor components
Fz4, the norrin receptor, was expressed in normal colonic
mucosa, the normal mucosa-derived colon cells,
NCM460, an endothelial cell line EaHy926, and each of
the tumorigenic colon cancer cell lines, including RKO
and HCT116, except Colo205 (Figure 1). LRP5, which is
essential for the transmission of norrin-induced canonical
Wnt signals, but may not be necessary for noncanonical
signaling, was found in fresh colonic tissue and all of the
cell lines tested (Figure 1). Similarly norrin mRNA was
detected in normal tissue and normal-derived and tumor-
igenic cell lines. These studies utilized reverse tran-
scriptase (RT)-PCR, not real time PCR, so do not provide
quantitative information as to the degree of expression.
Confirmation that PCR products represented the specific
genes under investigation was attained by direct sequence
analysis. Therefore, normal colonic tissue, endothelial
cells and normal-derived and cancer-derived colonic cell
lines (except for Colo205) express all of the components
necessary for norrin-driven canonical (β-catenin-depend-
ent) Wnt signaling.
Canonical Wnt signaling in NCM460 and RKO
Several methodologies were utilized to define the activity
of canonical Wnt signaling in NCM460 and RKO cells.
Incubation with Wnt3a conditioned medium (CM)
resulted in a small but statistically significant (p = 0.017)
increase in Wnt pathway throughput, measured by lumi-
nescence following transient transfection of the Super
Topflash reporter construct, in NCM460 cells and a robust
and highly significant increase (p < 0.0001) in RKO cells
(Figure 2A). NCM460 cells and RKO cells were also incu-
bated in side-by-side co-culture with Cell-tracker-labeled
RKO cells which had been previously transfected with a
Wnt2 expression plasmid (RKO/Wnt2). Wnt2 production
by these cells in culture was confirmed by Western blot of
RKO/Wnt2 cell lysates (see Figure 3D). Prior studies dem-
onstrated that Wnt 2 induced nuclear β-catenin transloca-
tion, a marker of canonical Wnt pathway activation in
RKO cells (data not shown). RKO cells responded with a
highly significant increase (p < 0.001) in Wnt throughput
but NCM460 cells exhibited decreased Wnt activity (p =
0.027; Figure 2B). To confirm this effect of differential
response to Wnt2 between the two cell lines, with a differ-
ent methodology, NCM460 cells and RKO cells were
directly transfected with a Wnt2 expression construct.
These experiments confirmed a significant reduction (p <
0.0001) in Wnt throughput in NCM460 and increase in
RKO cells (Figure 2C). Canonical Wnt pathway through-
put in these cells was further examined in side-by-side co-
culture with Wnt5a and Wnt1 producing cells. Exposure
to Wnt5a, which is known to signal via non-canonical
pathways in several experimental systems [27], did not
affect canonical Wnt activity in either cell. Exposure to
Wnt1, a strong inducer of canonical Wnt signals [28], sig-
nificantly increased Wnt throughput in RKO cells (p <
0.0001) but, similar to Wnt2, decreased Wnt throughput
in NCM460 cells (p = 0.002, Figure 2D).BMC Cell Biology 2007, 8:12 http://www.biomedcentral.com/1471-2121/8/12
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Effect of Wnt2 on Fz4 expression
NCM460, HCT116 and RKO cells were incubated in par-
titioned co-culture with Wnt2 producing cells. Under
these conditions, Wnt2 eliminates Fz4 mRNA expression
in NCM460 cells but not in RKO cells or HCT116 cells
(Figure 3A, 3B). The presence of Fz4 mRNA was deter-
mined by RT-PCR with specific oligonucleotide primers.
The loss of detectable Fz4 mRNA in NCM460 was uni-
formly confirmed in six separate experiments and was
seen only when co-cultured with Wnt2-producing cells
and not when co-cultured with sham-transfected (pCMV
plasmid containing) cells. The effect was not seen follow-
ing co-culture with cells transfected with a Wnt5a expres-
sion construct (Figure 3C). Expression of Fz1, 2, 3, 5, 6, 7,
8, 9 and 10 was not affected by Wnt 2 (Fz2 represented in
Figure 3B). To determine whether the loss of Fz4 message
resulted in changes in Fz4 protein expression at the cell
surface, a norrin-binding assay, utilizing soluble AP-3myc
norrin, was performed (Figure 4A). Exposure of NCM460
to Wnt2 significantly reduced norrin binding activity (p <
0.01), indicating a reduction in the cell surface expression
of Fz receptor capable of binding norrin and suggesting
that this is directly resultant from the abrogation of Fz4
gene expression. No significant change in norrin binding
activity was seen for RKO cells after exposure to Wnt2,
consistent with the RT-PCR data. Norrin binding activity
in NCM460 and RKO was not affected by incubation with
Wnt3a CM (Figure 4B).
Discussion and conclusion
Study of the extracellular and cell surface components of
the Wnt pathway in tumors and adjacent tissues has
received increased attention with the recognition that,
even in the face of activating mutations in the pathway
present in many cancers, the Wnt signal throughput can
be modified by promoting or inhibiting signaling through
the cell surface receptors [29,30]. In this report, we dem-
onstrate that the components for an alternative mecha-
nism of Wnt pathway activation, via norrin and Fz4, are
fully present in normal colonic mucosa, a normal-mucosa
derived cell line, an endothelial cell line and most colon
cancer cell lines. In the tumor microenvironment, tumor-
derived or mucosa-derived norrin may be available for
interaction with mucosal and endothelial Fz4. The availa-
Expression of norrin signaling components Figure 1
Expression of norrin signaling components. Panel A – RT-PCR for norrin signaling pathway components Fz4 (832 bp), norrin 
(400 bp), and LRP5 (300 bp) in normal colonic mucosa obtained fresh from colonoscopic biopsy. Molecular weight markers 
appear in lane 1. β-actin (544 bp) was utilized as a control to confirm RNA quality. Control PCR reactions without reverse 
transcriptase did not give any PCR products for any RNA sample with any pair of primers (data not shown). Identities of the 
PCR products were confirmed by sequence analysis. Panel B – Expression defined by RT-PCR of Fz4 (top row), norrin (3rd 
row) and LRP5 (bottom row) in various cell lines. Lane 1: no template control; lane 2: CSC1; lane 3: Colo205; lane 4: Colo320; 
lane 5: HCT116; lane 6: HCT116 with additional chromosome 3; lane 7: HT29; lane 8: NCM460 (normal mucosa-derived); lane 
9: RKO; lane 10: EaHy926 (endothelial). Fz4, norrin and LRP5 mRNA was detected in all tested cell lines with the exception of 
Fz4 in Colo205. Actin control is depicted in 2nd row.BMC Cell Biology 2007, 8:12 http://www.biomedcentral.com/1471-2121/8/12
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bility of LRP5 implies that signaling through norrin:Fz4
interactions could lead to canonical pathway activation
[12].
This is the first report in a mammalian system where a spe-
cific Wnt ligand (Wnt2) decreases the expression of a spe-
cific Fz receptor subtype (Fz4), without affecting the
expression of other Fz receptors. The effect was confirmed
at both the RNA level, by reverse transcriptase PCR, and at
the protein level, with a norrin binding assay. Further-
more, we demonstrate a degree of tissue specificity: Wnt2
decreases Fz4 expression in the normal-derived cells but
not in β-catenin-mutated (HCT116) or non-APC and
non-β-catenin mutated (RKO) colon cancer cells. Since
Responsiveness of NCM460 and RKO cells to Wnt stimulation Figure 2
Responsiveness of NCM460 and RKO cells to Wnt stimulation. Wnt pathway throughput is measured following transient 
transfection of the luciferase-based SuperTopflash reporter construct. All experiments were performed in conjunction with 
Renilla luciferase determination to control for cell numbers, viability and transfection efficiency. All experiments were repeated 
at least three times and performed each time in triplicate. Panel A – Incubation with Wnt3a conditioned medium (CM) slightly, 
but significantly increased Wnt pathway throughput in NCM460 (p = 0.017) and very dramatically in RKO (p < 0.0001). Panel 
B – Exposure to Wnt2 producing cells in side-by-side (SbS) co-culture decreased Wnt pathway throughput in NCM460 cells (p 
= 0.027) but increased Wnt pathway throughput in RKO (p < 0.001). Panel C – Direct transfection of a Wnt2 expressin con-
struct decreased Wnt pathway throughput in NCM460 (p < 0.0001) and increased Wnt pathway throughput in RKO (p < 
0.0001). Panel D – In SbS co-culture with either Wnt1 or Wnt5a producing cells, Wnt pathway throughput was decreased by 
Wnt1 (p = 0.002) but unchanged by Wnt5a in NCM460 cells, and increased by Wnt1 (p < 0.0001) but unchanged by Wnt5a in 
RKO cells.
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norrin activates canonical Wnt signaling [13,14], the
retention of Fz4 expression by the colon cancer-derived
cell lines would favor continued stimulation with this lig-
and, even in the presence of Wnt2 which is known to be
overexpressed by many colon cancers [24]. On the other
hand, downregulation of Fz4 in normal mucosa may pro-
tect it from stimulation by norrin or other Wnt ligands
present within the tumor microenvironment. Wnt2 did
not downregulate the expression of other frizzled recep-
tors, including Fz2. Therefore, both normal and tumori-
genic cells would retain the capacity to respond to
stimulation by extracellular Wnt ligands utilizing Fz2 or
other Fz receptors.
Autoregulation within the Wnt pathway, whereby Wnt
signaling affects the expression of genes encoding proteins
within its own pathway has been noted previously. Wnt3a
has been shown by microarray analysis in human terato-
carcinoma cells to increase the expression of Fz7 [31] and
Wg (wingless) is known to inhibit the expression of DFz2
in  Drosophila  [32]. This is the first report, however,
describing Wnt-dependent regulation of the norrin recep-
tor, Fz4, suggesting the existence of crosstalk between the
Wnt- and norrin-signaling pathways. The lack of effect of
Wnt3a (measured by norrin binding assay) and Wnt5a
(measured by RT-PCR) on Fz4 expression suggests that the
downregulation is Wnt2 specific. Mikels and Nusse [33]
RT-PCR results of Fz4 mRNA expression in normal mucosa-derived NCM460 cells and the colon cancer cell lines HCT116  and RKO following exposure to Wnt-producing cells in co-culture or cells transfected with a non-Wnt-producing pCMV con- trol plasmid Figure 3
RT-PCR results of Fz4 mRNA expression in normal mucosa-derived NCM460 cells and the colon cancer cell lines HCT116 
and RKO following exposure to Wnt-producing cells in co-culture or cells transfected with a non-Wnt-producing pCMV con-
trol plasmid. The Fz4 RT-PCR product was 832 bp. All experiments were performed simultaneously with actin primers, pro-
ducing a 544 bp product for quality control. Fz4 mRNA was downregulated by Wnt2 in normal colonic mucosa-derived 
NCM460 cells but not in the colon cancer cell lines. No effect on Fz4 expression following exposure to Wnt5a was seen. A. 
NCM460, HCT116 and RKO cells co-cultured using inserts with sham-transfected cells. B. NCM460, HCT116 and RKO co-
cultured with Wnt2-producing cells. C. NCM460 co-cultured with Wnt5a-producing cells. D. Wnt 2 and Wnt5a production by 
transfected RKO; Western blot. A non-specific band is present in all 3 lanes, including control. The Wnt2 and Wnt5a specific 
bands are annotated with an arrow.BMC Cell Biology 2007, 8:12 http://www.biomedcentral.com/1471-2121/8/12
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Norrin binding activity of NCM460 and RKO cells after partitioned co-culture Figure 4
Norrin binding activity of NCM460 and RKO cells after partitioned co-culture. Norrin binding was downregulated by Wnt2, 
but not Wnt3a in normal colonic mucosa-derived NCM460 cells. Each experiment was repeated three times with six (panel A) 
or five (panel B) replicates for each data point. A. Comparison of norrin binding in NCM460 (left) and RKO (right) after expo-
sure to sham-transfected cells and Wnt2-producing cells in partitioned co-culture (Pcc). The decrease in norrin binding in 
NCM460 is highly statistically significant (p < 0.01). B. Comparison of norrin binding in NCM460 (left) and RKO (right) after 
exposure to control (L-cell) and Wnt3a conditioned medium (CM). No statistically significant difference was seen.
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have shown that Wnt5a can signal through canonical or
non-canonical pathways, dependent on the cellular con-
text, with non-canonical signals antagonist to canonical
signaling. Wnt2 has been previously described to signal
both canonically [34] and non-canonically [35]. Our data
supports the idea that the intracellular response to Wnt2
may also be context dependent, in that this ligand reduced
Wnt throughput, and abrogated Fz4 expression, in
NCM460 but increased Wnt throughput, and did not
abrogate Fz4 expression, in RKO and HCT116. Whether
this difference relates to the origin of the cells (normal
mucosa vs. tumor), or whether the decrease in Fz4 expres-
sion is restricted to cells like NCM460 which exhibit a rel-
atively poor response to canonical signals, remains to be
defined. Interestingly, stimulation with a strongly canon-
ical Wnt ligand, Wnt1 [28], also led to a reduction in Wnt
signal throughput in NCM460, suggesting that signaling
induced by this ligand can also be context dependent.
The precise role of norrin-based signaling in gastrointesti-
nal tract and in the tumor microenvironment is unknown.
Our data on cell lines in vitro suggests that colonic tumors
may have available two autoregulatory stimulatory loops,
one which operates via interactions between Wnt2 (or
other Wnt ligands) and various Fz receptors and one that
operates via interactions between norrin and Fz4. While
human cancers have been shown to overexpress various
Wnt ligands [24], the level of norrin expression in human
colon cancers remains to be defined.
Regulation of Fz4 expression in normal colonic mucosa
may be critical for modulation of Fz4-based (both Wnt
and norrin initiated) signaling in the tumor microenvi-
ronment. Inhibition of Fz4 expression due to tumor-
derived Wnt2 would decrease Fz4-dependent signal
throughput, whereas tumor- or normal colonic mucosa-
derived norrin would promote Fz4-dependent signal
throughput. A balance between these opposing forces
may be important for maintaining colonic mucosal integ-
rity. Because of the known effects of Wnt signaling on gas-
trointestinal stem cells [1,36], we would also postulate
that control of Fz4 expression on colonic mucosal stem
cells may play some role in regulating stem cell differenti-
ation.
Additional studies are underway to define whether Wnt2
has similar effect on endothelial cell Fz4 in tumor vascu-
lature as it does on normal colon mucosa-derived cells.
Given the known relationship of mutated norrin and Fz4
to abnormal vascularization in the eye and ear [13,14],
perturbations in norrin:Fz4 signaling may be one explana-
tion for the disorganized and "leaky" neovascularization
which accompanies tumor-stimulated angiogenesis [37].
Our data in an endothelial cell line indicate that all of the
components necessary for norrin:Fz4 signaling are
present. Finally, the role of norrin in the colon cancer
needs further exploration in order to define whether this
arm of the "Wnt" signaling pathway may be a suitable tar-
get for cancer prevention or cancer therapy.
Methods
Human tissue acquisition
Biopsy specimens of normal colonic tissue were obtained
during diagnostic colonoscopy following informed con-
sent under an IRB-approved protocol at the H.H. Chao
Comprehensive Digestive Disease Center at the University
of California, Irvine. Tissue was incubated at +4°C in
RNAlater (Ambion, Austin, Texas) overnight then stored
frozen at -80°C. Tissue was subsequently homogenized
and mRNA was isolated with a TRIzol reagent (Invitrogen,
Carlsbad, California) according to standard protocols.
Normal colonic mucosa-derived and colon cancer cell lines
RKO, a human colon cancer cell line, was kindly provided
by Dr. Parker (UCLA). It was maintained in culture in
RPMI1640 media at 5% CO2 with 10% fetal bovine serum
(FBS). CSC1 and the normal mucosa-derived colon cell
line, NCM460 were obtained from Incell Corporation
(San Antonio, Texas). These cell lines were maintained in
M3 Base cell culture medium complete (Incell, catalog
number M300A-500) with 10% FBS. All other cell lines
were obtained from the American Type Culture Collection
(ATCC, Manassas, Virginia).
Side-by-side co-culture
RKO cells were plated in six-well dishes, grown until they
are ~60% confluent and transfected with either Wnt2 or
Wnt5a expression constructs (Upstate Biotechnology,
Lake Placid, New York) or, as a control, pCMV vector
without insert (Stratagene, La Jolla, California). For trans-
fection, 2 μg per well of DNA was added in 100 μl of Opti-
MEM I Reduced Serum Medium (Invitrogen, catalog No.
11058-021). Separately 6 μl of Lipofectamine 2000 (Inv-
itrogen, catalog No. 11668-019) were added to 100 μl of
Opti-MEM I. These two preparations were combined, and
mixed on shaker at room temperature for 20 minutes. The
cells were covered with 0.8 ml DMEM with 10% fetal
bovine serum. After the addition of the DNA-Lipo-
fectamine mixture, the cells were incubated overnight.
After rinsing, the cells were placed in culture with either
Super Topflash or Ranilla luciferase transfected RKO cells
or NCM460 cells.
Partitioned co-culture
For analysis of the effect of Wnt ligands on Fz4 expression
and for the norrin binding assay, a partitioned co-culture
system was utilized. RKO cells were transfected as indi-
cated above, and layered in 6 well plates. Untransfected
NCM460, HCT116 or RKO cells were plated on 0.4 μm
pore size PET track-etched membrane (Becton DickinsonBMC Cell Biology 2007, 8:12 http://www.biomedcentral.com/1471-2121/8/12
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Biosciences, San Jose, California, catalog No. 35-3090),
and grown until 30% confluence. These membrane-bot-
tomed receptacles served as cell culture inserts. The inserts
with target cells were placed over transfected Wnt-produc-
ing or sham-transfected RKO cells, and co-cultured for 24
hours. In this system, proteins secreted by the transfected
cells can directly influence target cells because they share
the same media. In the partitioned co-culture system,
Wnt2 and Wnt5a protein are secreted by the transfected
cells (prepared as described above). By utilizing the HA-
tag and specific antibodies, they can be detected by West-
ern blotting. Thus, this system permits the measurement
of cellular effects in the target cells of secreted Wnt ligands
and maintains a separate population of untransfected
cells which can be harvested for analysis. Following co-
culture, target cells were harvested from the membranes
for analysis of Fz4 expression and for the norrin binding
assay.
Conditioned Medium
Wnt3a conditioned medium (CM) was prepared accord-
ing to procedures perfected in the laboratory of Dr. R
Nusse [25,26].
Reverse transcriptase PCR
RNA was purified using TRIzol reagent according to the
manufacturer's procedure (Invitrogen) and dissolved in
20 μl of DEPC-treated water. 1 μg of the RNA was treated
with Deoxyribonuclease I (Invitrogen, catalog No. 18068-
015). Reverse transcriptase PCR was done applying Super-
Script One-Step RT-PCR for Long Templates (Invitrogen,
catalog No. 11922-028) with PTC programmable thermal
controller (MJ Research, Inc.) according to the manufac-
turers' procedures. Primer sets for actin (control for RNA
sample's quality), Fz4, norrin and LRP5 were kindly pro-
vided by Drs. Tim Byun, Xiaolin Zi and Yi Guo. The
thermo-cycler parameters were: 30 min, 55°C; 2 min
94°C; 40 cycles of: 15 sec 94°C, 30 sec 55°C and 1 min
72°C; final extension of 10 min, 72°C. Reaction products
were analyzed by electrophoresis on 0.8% agarose gels.
Quantitative estimation of luciferase activity
To evaluate Wnt pathway throughput following transient
transfection of a Super Topflash reporter construct which
contains repeated LEF/TCF binding sites preceding a luci-
ferase reporter, a Dual-Glo Luciferase Assay System
(Promega, Madison, WI) was used, following manufactur-
ers instructions and utilizing 50 μl of firefly luciferase sub-
strate. After incubation at room temperature for 10 min,
the luminescence was measured using ML 3000 Microtiter
Plate Luminometer (Dynatech Laboratories, Orlando,
FL). After that 50 μl of Renilla luciferase substrate were
added, and the luminescence was measured again.
(Renilla luciferase expression construct pRstF was kindly
provided by Dr. R. Gesteland from University of Utah.)
Renilla luciferase data were used to normalize for transfec-
tion efficiency and changes in cell survival and growth.
Norrin binding assay
After 24 hours of partitioned co-culture, cells in the inserts
were transferred to new 6 well plates on ice. Norrin-con-
ditioned medium, generated after 24 hours of culture in
cells transfected with an alkaline phosphatase-3myc-
mNorrin conjugate expression construct, generously pro-
vided by Dr. J. Nathans, was added both inside (1 ml) and
outside (2 ml) of the insert. The cells were kept on ice for
1 hour, rinsed, and treated with 0.25 ml 1% Triton X-100
in HBS. A disposable cell scraper was utilized to collect the
cells. A Great EscApe SEAP kit (Becton Dickinson, catalog
No. 631701) was used to measure the alkaline phos-
phatase bound to the target cells. 15 μl of the lysate was
added to 45 μl 1× Dilution Buffer in 96 well black assay
plate with clear bottom, tissue culture treated (Corning
Incorporated, New York, catalog No. 3603). The plate was
wrapped into a plastic wrap and incubated for 30 min
65°C to inactivate endogenous cellular phosphatases.
After the addition of the substrate, chemiluminescence
was measured using an ML 3000 Microtiter Plate Lumi-
nometer (Dynatech Laboratories, Chantilly, Virginia).
This norrin-alkaline phosphatase chimera does not
induce Wnt signaling and is utilized only to define the
degree of Fz4 expression via a binding assay.
Western blot analysis
Whole cell protein extracts from transfected cells were pre-
pared using a 1× loading buffer solution containing 5 mM
Tris-Cl, pH 6.8, 2% SDS and 10% glycerol and separatated
by SDS-polyacrylamide gel electrophoresis. Following
transfer to nitrocellulose, blots were treated with 5% dried
mild in 1× PBS to block non-specific binding, washed,
and incubated with primary antibody in 0.1% Tween-20/
PBS for 1 hour at room temperature and subsequently
overnight at 4°C. Transfection efficiency analysis was per-
formed in the transfected RKO cells using an anti-HA pol-
yclonal primary antibody (Santa Cruz Biotechnology) at a
dilution of 1:1000. All membranes were re-blotted with
an anti-actin polyclonal antibody at a dilution of 1:1000
to allow for normalization between lanes and experi-
ments. After washes, blots were incubated with a conju-
gate of horseradish-peroxidase secondary antibodies in 1×
PBS/0.1% Tween-20. Peroxidase localization was deter-
mined using a chemiluminescence kit (Pierce, Woburn,
MA). Intensity of bands was defined by light transmit-
tance densitometry (BioRad, Hercules, CA).
Statistical considerations
Means and standard deviations for all experimental data
were calculated. Comparisons between different experi-
mental conditions were made using a 2-tailed t-test for
unpaired samples with an α < 0.05 for significance.BMC Cell Biology 2007, 8:12 http://www.biomedcentral.com/1471-2121/8/12
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